RESISTANCE TO CISPLATIN AND ANALOGS - MECHANISMS AND POTENTIAL CLINICAL IMPLICATIONS

被引：110
作者：
DEGRAEFF, A
SLEBOS, RJC
RODENHUIS, S
机构：
[1] NETHERLANDS CANC INST, DIV EXPTL THERAPY, PLESMANLAAN 121, 1066 CX AMSTERDAM, NETHERLANDS
[2] NETHERLANDS CANC INST, DIV CLIN ONCOL, 1066 CX AMSTERDAM, NETHERLANDS
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1988年 / 22卷 / 04期
关键词：
D O I：
10.1007/BF00254240
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：325 / 332
页数：8
相关论文
共 103 条
[51]  
KOHN KW, 1981, DNA REPAIR LABORATOR, V1, P379
[52]   BINDING OF CIS-DICHLORODIAMMINE PLATINUM(II) TO METALLOTHIONEIN IN EHRLICH CELLS [J].
KRAKER, A ;
SCHMIDT, J ;
KREZOSKI, S ;
PETERING, DH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 130 (02) :786-792
[53]  
KRAKER AJ, 1986, P AM ASSOC CANC RES, V27, P286
[54]  
KUPPEN PJK, 1987, 4TH P EUR C CLIN ONC, P81
[55]  
LAURENT G, 1981, CANCER RES, V41, P3347
[56]   DRUGS 5 YEARS LATER - CISPLATIN [J].
LOEHRER, PJ ;
EINHORN, LH .
ANNALS OF INTERNAL MEDICINE, 1984, 100 (05) :704-713
[57]  
MASUDA H, 1986, P AM ASSOC CANC RES, V27, P264
[58]  
MCVIE JG, 1984, ANTITUMOR DRUG RESIS, P39
[59]   POSSIBLE MECHANISM FOR DIFFERENCES IN SENSITIVITY TO CISPLATINUM IN HUMAN-PROSTATE TUMOR-CELL LINES [J].
METCALFE, SA ;
CAIN, K ;
HILL, BT .
CANCER LETTERS, 1986, 31 (02) :163-169
[60]  
MICETICH K, 1983, CANCER RES, V43, P3609
12345678910